Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 803 entries
Sorted by: Best Match Show Resources per page
Assessing diversity and inclusion within the UK's geochemistry academic workforce

Stem workforce diversity

Anand P, Bots P.
GSID: dfjbyOGiM9sJ
P Anand, F Appiah, A Lawrence, P Bots… - 2022 - meetingorganizer.copernicus.org

Geochemistry is applied across Earth, environmental and planetary geoscience research. Yet, the first specific workforce diversity data for geochemistry is only now being collected (eg EAG-GS led 2022 Global Geochemistry Community Survey). Additionally, national effort is underway to scrutinise...

Cite
Anand, P., Appiah, F., Lawrence, A., Bots, P., Gagnon, J., Bhagwat, S., ... & Ngwenya, B. (2022). Assessing diversity and inclusion within the UK’s geochemistry academic workforce (No. EGU22-8410). Copernicus Meetings.
Anand, Pallavi, et al. Assessing diversity and inclusion within the UK’s geochemistry academic workforce. No. EGU22-8410. Copernicus Meetings, 2022.
Copy Download .nbib Format: MLA
Diversity, equity, and inclusion: Tackling under-representation and recognition of talents in geochemistry and cosmochemistry

Geoscience Opportunities for Leadership in Diversity AND Program Evaluation

Anand P, Arndt S, Bots P, Dosseto A, Pourret O.
GSID: QosasJsQNPsJ
O Pourret, P Anand, S Arndt, P Bots, A Dosseto… - … et Cosmochimica Acta, 2021 - Elsevier

Diversity, at every step along the scientific path, drives innovative research. Scientific societies, like the Geochemical Society (GS) and the European Association of Geochemistry (EAG), have a significant influence over which discoveries and innovators are celebrated. Such choices impact...

Cite
Pourret, O., Anand, P., Arndt, S., Bots, P., Dosseto, A., Li, Z., ... & Riches, A. J. (2021). Diversity, equity, and inclusion: Tackling under-representation and recognition of talents in geochemistry and cosmochemistry. Geochimica et Cosmochimica Acta, 310, 363-371.
Pourret, Olivier, et al. "Diversity, equity, and inclusion: Tackling under-representation and recognition of talents in geochemistry and cosmochemistry." Geochimica et Cosmochimica Acta 310 (2021): 363-371.
Copy Download .nbib Format: MLA
Targeting Ion Channels: An Important Therapeutic Implication in Gastrointestinal Dysmotility in Patients With Spinal Cord Injury.

Journal of neurogastroenterology and motility

Radulovic M, Anand P, Korsten MA, Gong B.
PMID: 26424038
J Neurogastroenterol Motil. 2015 Oct 01;21(4):494-502. doi: 10.5056/jnm15061.

Gastrointestinal (GI) dysmotility is a severe, and common complication in patients with spinal cord injury (SCI). Current therapeutic methods using acetylcholine analogs or laxative agents have unwanted side effects, besides often fail to have desired effect. Various ion channels...

Cite
Radulovic M, Anand P, Korsten MA, et al. Targeting Ion Channels: An Important Therapeutic Implication in Gastrointestinal Dysmotility in Patients With Spinal Cord Injury. J Neurogastroenterol Motil. 2015;21(4):494-502doi: 10.5056/jnm15061.
Radulovic, M., Anand, P., Korsten, M. A., & Gong, B. (2015). Targeting Ion Channels: An Important Therapeutic Implication in Gastrointestinal Dysmotility in Patients With Spinal Cord Injury. Journal of neurogastroenterology and motility, 21(4), 494-502. https://doi.org/10.5056/jnm15061
Radulovic, Miroslav, et al. "Targeting Ion Channels: An Important Therapeutic Implication in Gastrointestinal Dysmotility in Patients With Spinal Cord Injury." Journal of neurogastroenterology and motility vol. 21,4 (2015): 494-502. doi: https://doi.org/10.5056/jnm15061
Radulovic M, Anand P, Korsten MA, Gong B. Targeting Ion Channels: An Important Therapeutic Implication in Gastrointestinal Dysmotility in Patients With Spinal Cord Injury. J Neurogastroenterol Motil. 2015 Oct 01;21(4):494-502. doi: 10.5056/jnm15061. PMID: 26424038; PMCID: PMC4622131.
Copy Download .nbib Format: NLM
Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India.

Journal of clinical and experimental hepatology

Puri P, Anand AC, Saraswat VA, Acharya SK, Dhiman RK, Aggarwal R, Singh SP, Amarapurkar D, Arora A, Chhabra M, Chetri K, Choudhuri G, Dixit VK, Duseja A, Jain AK, Kapoorz D, Kar P, Koshy A, Kumar A, Madan K, Misra SP, Prasad MV, Nagral A, Puri AS, Jeyamani R, Saigal S, Sarin SK, Shah S, Sharma PK, Sood A, Thareja S, Wadhawan M.
PMID: 25755548
J Clin Exp Hepatol. 2014 Jun;4(2):106-16. doi: 10.1016/j.jceh.2014.05.006. Epub 2014 Jun 09.

Globally, around 150 million people are infected with hepatitis C virus (HCV). India contributes a large proportion of this HCV burden. The prevalence of HCV infection in India is estimated at between 0.5% and 1.5%. It is higher in...

Cite
Puri P, Anand AC, Saraswat VA, et al. Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India. J Clin Exp Hepatol. 2014;4(2):106-16doi: 10.1016/j.jceh.2014.05.006.
Puri, P., Anand, A. C., Saraswat, V. A., Acharya, S. K., Dhiman, R. K., Aggarwal, R., Singh, S. P., Amarapurkar, D., Arora, A., Chhabra, M., Chetri, K., Choudhuri, G., Dixit, V. K., Duseja, A., Jain, A. K., Kapoorz, D., Kar, P., Koshy, A., Kumar, A., Madan, K., Misra, S. P., Prasad, M. V., Nagral, A., Puri, A. S., Jeyamani, R., Saigal, S., Sarin, S. K., Shah, S., Sharma, P. K., Sood, A., Thareja, S., & Wadhawan, M. (2014). Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India. Journal of clinical and experimental hepatology, 4(2), 106-16. https://doi.org/10.1016/j.jceh.2014.05.006
Puri, Pankaj, et al. "Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India." Journal of clinical and experimental hepatology vol. 4,2 (2014): 106-16. doi: https://doi.org/10.1016/j.jceh.2014.05.006
Puri P, Anand AC, Saraswat VA, Acharya SK, Dhiman RK, Aggarwal R, Singh SP, Amarapurkar D, Arora A, Chhabra M, Chetri K, Choudhuri G, Dixit VK, Duseja A, Jain AK, Kapoorz D, Kar P, Koshy A, Kumar A, Madan K, Misra SP, Prasad MV, Nagral A, Puri AS, Jeyamani R, Saigal S, Sarin SK, Shah S, Sharma PK, Sood A, Thareja S, Wadhawan M. Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India. J Clin Exp Hepatol. 2014 Jun;4(2):106-16. doi: 10.1016/j.jceh.2014.05.006. Epub 2014 Jun 09. PMID: 25755548; PMCID: PMC4116733.
Copy Download .nbib Format: NLM
Diode Laser Assisted Excision and Low Level Laser Therapy in the Management of Mucus Extravasation Cysts: A Case Series.

Journal of lasers in medical sciences

Ahad A, Tandon S, Lamba AK, Faraz F, Anand P, Aleem A.
PMID: 29123637
J Lasers Med Sci. 2017;8(3):155-159. doi: 10.15171/jlms.2017.28. Epub 2017 Jun 27.

No abstract available.

Cite
Ahad A, Tandon S, Lamba AK, et al. Diode Laser Assisted Excision and Low Level Laser Therapy in the Management of Mucus Extravasation Cysts: A Case Series. J Lasers Med Sci. 2017;8(3):155-159doi: 10.15171/jlms.2017.28.
Ahad, A., Tandon, S., Lamba, A. K., Faraz, F., Anand, P., & Aleem, A. (2017). Diode Laser Assisted Excision and Low Level Laser Therapy in the Management of Mucus Extravasation Cysts: A Case Series. Journal of lasers in medical sciences, 8(3), 155-159. https://doi.org/10.15171/jlms.2017.28
Ahad, Abdul, et al. "Diode Laser Assisted Excision and Low Level Laser Therapy in the Management of Mucus Extravasation Cysts: A Case Series." Journal of lasers in medical sciences vol. 8,3 (2017): 155-159. doi: https://doi.org/10.15171/jlms.2017.28
Ahad A, Tandon S, Lamba AK, Faraz F, Anand P, Aleem A. Diode Laser Assisted Excision and Low Level Laser Therapy in the Management of Mucus Extravasation Cysts: A Case Series. J Lasers Med Sci. 2017;8(3):155-159. doi: 10.15171/jlms.2017.28. Epub 2017 Jun 27. PMID: 29123637; PMCID: PMC5662506.
Copy Download .nbib Format: NLM
Single-shot measurement of the orbital-angular-momentum spectrum of light.

Nature communications

Kulkarni G, Sahu R, Magaña-Loaiza OS, Boyd RW, Jha AK.
PMID: 29057867
Nat Commun. 2017 Oct 20;8(1):1054. doi: 10.1038/s41467-017-01215-x.

The existing methods for measuring the orbital-angular-momentum (OAM) spectrum suffer from issues such as poor efficiency, strict interferometric stability requirements, and too much loss. Furthermore, most techniques inevitably discard part of the field and measure only a post-selected portion...

Cite
Kulkarni G, Sahu R, Magaña-Loaiza OS, et al. Single-shot measurement of the orbital-angular-momentum spectrum of light. Nat Commun. 2017;8(1):1054doi: 10.1038/s41467-017-01215-x.
Kulkarni, G., Sahu, R., Magaña-Loaiza, O. S., Boyd, R. W., & Jha, A. K. (2017). Single-shot measurement of the orbital-angular-momentum spectrum of light. Nature communications, 8(1), 1054. https://doi.org/10.1038/s41467-017-01215-x
Kulkarni, Girish, et al. "Single-shot measurement of the orbital-angular-momentum spectrum of light." Nature communications vol. 8,1 (2017): 1054. doi: https://doi.org/10.1038/s41467-017-01215-x
Kulkarni G, Sahu R, Magaña-Loaiza OS, Boyd RW, Jha AK. Single-shot measurement of the orbital-angular-momentum spectrum of light. Nat Commun. 2017 Oct 20;8(1):1054. doi: 10.1038/s41467-017-01215-x. PMID: 29057867; PMCID: PMC5715088.
Copy Download .nbib Format: NLM
Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation.

Hematology reports

Jillella AP, Arellano ML, Heffner LT, Gaddh M, Langston AA, Khoury HJ, Mangoankar A, Kota VK.
PMID: 29071052
Hematol Rep. 2017 Sep 26;9(3):7083. doi: 10.4081/hr.2017.7083. eCollection 2017 Sep 26.

No abstract available.

Cite
Jillella AP, Arellano ML, Heffner LT, et al. Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation. Hematol Rep. 2017;9(3):7083doi: 10.4081/hr.2017.7083.
Jillella, A. P., Arellano, M. L., Heffner, L. T., Gaddh, M., Langston, A. A., Khoury, H. J., Mangoankar, A., & Kota, V. K. (2017). Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation. Hematology reports, 9(3), 7083. https://doi.org/10.4081/hr.2017.7083
Jillella, Anand P, et al. "Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation." Hematology reports vol. 9,3 (2017): 7083. doi: https://doi.org/10.4081/hr.2017.7083
Jillella AP, Arellano ML, Heffner LT, Gaddh M, Langston AA, Khoury HJ, Mangoankar A, Kota VK. Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation. Hematol Rep. 2017 Sep 26;9(3):7083. doi: 10.4081/hr.2017.7083. eCollection 2017 Sep 26. PMID: 29071052; PMCID: PMC5641824.
Copy Download .nbib Format: NLM
Evaluation of NS1 Antigen Detection for Early Diagnosis of Dengue in a Tertiary Hospital in Southern India.

Journal of clinical and diagnostic research : JCDR

Anand AM, Sistla S, Dhodapkar R, Hamide A, Biswal N, Srinivasan B.
PMID: 27190798
J Clin Diagn Res. 2016 Apr;10(4):DC01-4. doi: 10.7860/JCDR/2016/15758.7562. Epub 2016 Apr 01.

INTRODUCTION: Dengue is a mosquito-borne disease affecting mainly tropical and subtropical regions of the world. The early diagnosis of dengue is required for identifying an epidemic and also for implementing effective vector control measures.AIM: To evaluate NS1 antigen assay...

Cite
Anand AM, Sistla S, Dhodapkar R, et al. Evaluation of NS1 Antigen Detection for Early Diagnosis of Dengue in a Tertiary Hospital in Southern India. J Clin Diagn Res. 2016;10(4):DC01-4doi: 10.7860/JCDR/2016/15758.7562.
Anand, A. M., Sistla, S., Dhodapkar, R., Hamide, A., Biswal, N., & Srinivasan, B. (2016). Evaluation of NS1 Antigen Detection for Early Diagnosis of Dengue in a Tertiary Hospital in Southern India. Journal of clinical and diagnostic research : JCDR, 10(4), DC01-4. https://doi.org/10.7860/JCDR/2016/15758.7562
Anand, Ashwini Manoor, et al. "Evaluation of NS1 Antigen Detection for Early Diagnosis of Dengue in a Tertiary Hospital in Southern India." Journal of clinical and diagnostic research : JCDR vol. 10,4 (2016): DC01-4. doi: https://doi.org/10.7860/JCDR/2016/15758.7562
Anand AM, Sistla S, Dhodapkar R, Hamide A, Biswal N, Srinivasan B. Evaluation of NS1 Antigen Detection for Early Diagnosis of Dengue in a Tertiary Hospital in Southern India. J Clin Diagn Res. 2016 Apr;10(4):DC01-4. doi: 10.7860/JCDR/2016/15758.7562. Epub 2016 Apr 01. PMID: 27190798; PMCID: PMC4866096.
Copy Download .nbib Format: NLM
Venous aneurysm complicating dialytic arteriovenous fistula.

The Indian journal of surgery

Nambiar AK, Anand KT, Jayakrishnan AG.
PMID: 24293907
Indian J Surg. 2012 Dec;74(6):491-2. doi: 10.1007/s12262-012-0526-4. Epub 2012 Jun 14.

A case of venous aneurysm complicating arteriovenous fistula created for chronic haemodialysis is presented. The patient underwent successful ligation and excision of the fistula and creation of a fistula on the opposite limb.

Cite
Nambiar AK, Anand KT, Jayakrishnan AG. Venous aneurysm complicating dialytic arteriovenous fistula. Indian J Surg. 2012;74(6):491-2doi: 10.1007/s12262-012-0526-4.
Nambiar, A. K., Anand, K. T., & Jayakrishnan, A. G. (2012). Venous aneurysm complicating dialytic arteriovenous fistula. The Indian journal of surgery, 74(6), 491-2. https://doi.org/10.1007/s12262-012-0526-4
Nambiar, Arjun K, et al. "Venous aneurysm complicating dialytic arteriovenous fistula." The Indian journal of surgery vol. 74,6 (2012): 491-2. doi: https://doi.org/10.1007/s12262-012-0526-4
Nambiar AK, Anand KT, Jayakrishnan AG. Venous aneurysm complicating dialytic arteriovenous fistula. Indian J Surg. 2012 Dec;74(6):491-2. doi: 10.1007/s12262-012-0526-4. Epub 2012 Jun 14. PMID: 24293907; PMCID: PMC3537981.
Copy Download .nbib Format: NLM
Heart-Type Fatty Acid Binding Protein: A Better Cardiac Biomarker than CK-MB and Myoglobin in the Early Diagnosis of Acute Myocardial Infarction.

Journal of clinical and diagnostic research : JCDR

Pyati AK, Devaranavadagi BB, Sajjannar SL, Nikam SV, Shannawaz M, Sudharani.
PMID: 26557510
J Clin Diagn Res. 2015 Oct;9(10):BC08-11. doi: 10.7860/JCDR/2015/15132.6684. Epub 2015 Oct 01.

BACKGROUND: Early diagnosis and therapeutic intervention can improve the outcome of acute myocardial infarction (AMI). However, there are no satisfactory cardiac biomarkers for the diagnosis of AMI within 6 hours of onset of symptoms. Among novel biochemical markers of...

Cite
Pyati AK, Devaranavadagi BB, Sajjannar SL, et al. Heart-Type Fatty Acid Binding Protein: A Better Cardiac Biomarker than CK-MB and Myoglobin in the Early Diagnosis of Acute Myocardial Infarction. J Clin Diagn Res. 2015;9(10):BC08-11doi: 10.7860/JCDR/2015/15132.6684.
Pyati, A. K., Devaranavadagi, B. B., Sajjannar, S. L., Nikam, S. V., Shannawaz, M., & Sudharani. (2015). Heart-Type Fatty Acid Binding Protein: A Better Cardiac Biomarker than CK-MB and Myoglobin in the Early Diagnosis of Acute Myocardial Infarction. Journal of clinical and diagnostic research : JCDR, 9(10), BC08-11. https://doi.org/10.7860/JCDR/2015/15132.6684
Pyati, Anand K, et al. "Heart-Type Fatty Acid Binding Protein: A Better Cardiac Biomarker than CK-MB and Myoglobin in the Early Diagnosis of Acute Myocardial Infarction." Journal of clinical and diagnostic research : JCDR vol. 9,10 (2015): BC08-11. doi: https://doi.org/10.7860/JCDR/2015/15132.6684
Pyati AK, Devaranavadagi BB, Sajjannar SL, Nikam SV, Shannawaz M, Sudharani. Heart-Type Fatty Acid Binding Protein: A Better Cardiac Biomarker than CK-MB and Myoglobin in the Early Diagnosis of Acute Myocardial Infarction. J Clin Diagn Res. 2015 Oct;9(10):BC08-11. doi: 10.7860/JCDR/2015/15132.6684. Epub 2015 Oct 01. PMID: 26557510; PMCID: PMC4625229.
Copy Download .nbib Format: NLM
Improving Outcome of Aplastic Anaemia with HLA-Matched Sibling Donor Hematopoietic Stem Cell Transplantation: An Experience of Gujarat Cancer and Research Institute (GCRI).

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Raut SS, Shah SA, Patel KA, Shah KM, Anand AS, Talati SS, Panchal HP, Patel AA, Parikh SK, Parekh BB, Shukla SN.
PMID: 25548437
Indian J Hematol Blood Transfus. 2015 Mar;31(1):1-8. doi: 10.1007/s12288-014-0397-x. Epub 2014 May 08.

Fifteen patients, with a median age of 19 years having severe aplastic anaemia (SAA) underwent human leucocyte antigen (HLA) identical sibling donor hematopoietic stem cell transplantation (HSCT) using conditioning regimens containing cyclophosphamide with antithymocyte globulin (ATG) or a combination...

Cite
Raut SS, Shah SA, Patel KA, et al. Improving Outcome of Aplastic Anaemia with HLA-Matched Sibling Donor Hematopoietic Stem Cell Transplantation: An Experience of Gujarat Cancer and Research Institute (GCRI). Indian J Hematol Blood Transfus. 2014;31(1):1-8doi: 10.1007/s12288-014-0397-x.
Raut, S. S., Shah, S. A., Patel, K. A., Shah, K. M., Anand, A. S., Talati, S. S., Panchal, H. P., Patel, A. A., Parikh, S. K., Parekh, B. B., & Shukla, S. N. (2015). Improving Outcome of Aplastic Anaemia with HLA-Matched Sibling Donor Hematopoietic Stem Cell Transplantation: An Experience of Gujarat Cancer and Research Institute (GCRI). Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, 31(1), 1-8. https://doi.org/10.1007/s12288-014-0397-x
Raut, Shreeniwas S, et al. "Improving Outcome of Aplastic Anaemia with HLA-Matched Sibling Donor Hematopoietic Stem Cell Transplantation: An Experience of Gujarat Cancer and Research Institute (GCRI)." Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion vol. 31,1 (2015): 1-8. doi: https://doi.org/10.1007/s12288-014-0397-x
Raut SS, Shah SA, Patel KA, Shah KM, Anand AS, Talati SS, Panchal HP, Patel AA, Parikh SK, Parekh BB, Shukla SN. Improving Outcome of Aplastic Anaemia with HLA-Matched Sibling Donor Hematopoietic Stem Cell Transplantation: An Experience of Gujarat Cancer and Research Institute (GCRI). Indian J Hematol Blood Transfus. 2015 Mar;31(1):1-8. doi: 10.1007/s12288-014-0397-x. Epub 2014 May 08. PMID: 25548437; PMCID: PMC4275516.
Copy Download .nbib Format: NLM
Genetic variation in the extended major histocompatibility complex and susceptibility to childhood acute lymphoblastic leukemia: a review of the evidence.

Frontiers in oncology

Urayama KY, Thompson PD, Taylor M, Trachtenberg EA, Chokkalingam AP.
PMID: 24377085
Front Oncol. 2013 Dec 12;3:300. doi: 10.3389/fonc.2013.00300.

The enduring suspicion that infections and immunologic response may play a role in the etiology of childhood leukemia, particularly acute lymphoblastic leukemia (ALL), is now supported, albeit still indirectly, by numerous epidemiological studies. The cumulative evidence includes, for example,...

Cite
Urayama KY, Thompson PD, Taylor M, et al. Genetic variation in the extended major histocompatibility complex and susceptibility to childhood acute lymphoblastic leukemia: a review of the evidence. Front Oncol. 2013;3:300doi: 10.3389/fonc.2013.00300.
Urayama, K. Y., Thompson, P. D., Taylor, M., Trachtenberg, E. A., & Chokkalingam, A. P. (2013). Genetic variation in the extended major histocompatibility complex and susceptibility to childhood acute lymphoblastic leukemia: a review of the evidence. Frontiers in oncology, 3300. https://doi.org/10.3389/fonc.2013.00300
Urayama, Kevin Y, et al. "Genetic variation in the extended major histocompatibility complex and susceptibility to childhood acute lymphoblastic leukemia: a review of the evidence." Frontiers in oncology vol. 3 (2013): 300. doi: https://doi.org/10.3389/fonc.2013.00300
Urayama KY, Thompson PD, Taylor M, Trachtenberg EA, Chokkalingam AP. Genetic variation in the extended major histocompatibility complex and susceptibility to childhood acute lymphoblastic leukemia: a review of the evidence. Front Oncol. 2013 Dec 12;3:300. doi: 10.3389/fonc.2013.00300. PMID: 24377085; PMCID: PMC3859964.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 803 entries